Inventor · disambiguated record
Gregory Conn
Also filed as: CONN GREGORY · CONN GREGORY L
12 granted patents·12 pending applications·191 citations·filing 1992–2024
92Inventor score
Top patents by PatentIndex Score
24 records- 0194US11801257B2Stimulation of an immune response by enantiomers of cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2020·Granted Oct 31, 2023·4 cites·13 claims
- 0292US10702541B2Stimulation of an immune response by enantiomers of cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2017·Granted Jul 7, 2020·7 cites·13 claims
- 0392US8877206B2Stimulation of an immune response by cationic lipidsCHEN WEIHSU·Filed 2008·Granted Nov 4, 2014·78 cites·44 claims
- 0489US6933134B2DNA molecules encoding vascular endothelial cell growth factor II subunitsMERCK & CO INC·Filed 2002·Granted Aug 23, 2005·15 cites·16 claims
- 0583US11911359B2Stimulation of an immune response by cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2014·Granted Feb 27, 2024·2 cites·21 claims
- 0683US9789129B2Stimulation of an immune response by enantiomers of cationic lipidsVASIEVICH ELIZABETH ANN·Filed 2009·Granted Oct 17, 2017·10 cites·4 claims
- 0777US5726152AVascular endothelial cell growth factor IIMERCK & CO INC·Filed 1994·Granted Mar 10, 1998·33 cites·10 claims
- 0877US2025018029A1Methods to alter the tumor microenvironment for effective cancer immunotherapyPDS BIOTECHNOLOGY CORP·Filed 2024·Application pending·0 cites
- 0971US2021346333A1Stimulation of an immune response by cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2021·Application pending·0 cites
- 1071US2022031650A1Stimulation of an immune response by cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2021·Application pending·0 cites
- 1169US2021308157A1Stimulation of an immune response by enantiomers of cationic lipidsPDS BIOTECHNOLOGY CORP·Filed 2021·Application pending·0 cites
- 1265US2024316178A1Recombinant protein vaccines formulated with enantio-specific cationic lipid r-dotap and methods of use thereofPDS BIOTECHNOLOGY CORP·Filed 2023·Application pending·0 cites
- 1365US2024317828A1T cell activating immunotherapeutic for treatment of mucin 1 protein expressing human cancersPDS BIOTECHNOLOGY CORP·Filed 2023·Application pending·0 cites
- 1465US2024317833A1Non-hla restricted t cell vaccine for tcr gamma alternate reading frame protein (tarp) protein expressing cancersPDS BIOTECHNOLOGY CORP·Filed 2023·Application pending·0 cites
- 1562US6143714AMethods of using hepatocyte growth factor to promote survival, growth and differentiation of motor neuronsREGENERON PHARMA·Filed 1997·Granted Nov 7, 2000·16 cites·4 claims
- 1662US5532343APurification and characterization of a glioma-derived growth factor having vascular endothelial cell growth promoting activityMERCK & CO INC·Filed 1994·Granted Jul 2, 1996·13 cites·2 claims
- 1762US5338840ADNA encoding glioma-derived growth factor having vascular endothelial cell growth promoting activityMERCK & CO INC·Filed 1992·Granted Aug 16, 1994·13 cites·1 claims
- 1853US6841658B2Purification of human Troponin IAKZO NOBEL NV·Filed 2001·Granted Jan 11, 2005·0 cites·16 claims
- 1952US2003138907A1Purification of human troponin IFiled 2002·Application pending·0 cites
- 2051US2019275145A1Particulate vaccine formulationsPDS BIOTECHNOLOGY CORP·Filed 2019·Application pending·0 cites
- 2148US2002064835A1Purification of human troponin IDIOSYNTH RTP INC·Filed 2001·Application pending·0 cites
- 2246US2015110823A1Particulate vaccine formulationsBEDU-ADDO FRANK·Filed 2012·Application pending·0 cites
- 2342US2003105017A1Purification of human Troponin IFiled 2002·Application pending·0 cites
- 2433US6180107B1Vascular endothelial cell growth factor IIMERCK & CO INC·Filed 1998·Granted Jan 30, 2001·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Gregory Conn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →